NSE
Caplin Point Laboratories LimitedCAPLIPOINT
Caplin Point Laboratories Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of pharmaceutical products. It focuses on producing high-quality medicines for various therapeutic areas.
| Key products | Pharmaceuticals, Vaccines |
|---|---|
| Geography | India, Middle East, Africa |
| Competitors | Dr. Reddy's Laboratories Limited, Cipla Limited |
AI-generated overview β verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 Β· tilt Neutral
Next corporate action
Interim Dividend - Rs 4 Per Share
ex 2026-05-29
| # | Company | Inst. flow βΉCr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | CAPLIPOINTThis | β | β | β | β | β | β |
| 2 | ACMESOLAR | β | β | β | β | +3 | 6 |
| 3 | AADHARHFC | β | β | β | β | β | β |
| 4 | AARTIIND | β | β | β | β | β | β |
| 5 | ACE | β | β | β | β | β | β |
| 6 | ACUTAAS | β | β | β | β | +4 | 6 |
| 7 | ABLBL | β | β | β | β | β | β |
| 8 | AAVAS | ββΉ1.9 Cr | 2 | β | β | β | β |
| 9 | ABFRL | ββΉ142.6 Cr | 2 | β | β | β | β |
Ranked by net institutional flow (buys β sells, βΉCr). Filing momentum = bullish β bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Strengths
- β’ [object Object]
- β’ [object Object]
Opportunities
- β’ [object Object]
- β’ [object Object]
Threats
- β’ [object Object]
- β’ [object Object]
AI-generated from our data β verify before relying on it.
- 2026-06-16FilingCaplin Point Laboratories LimitedΒ has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) ofShareholding Disclosure
- 2026-05-29ActionInterim Dividend - Rs 4 Per ShareDividend
- 2025-09-12ActionDividend - Rs 3 Per ShareDividend
- 2025-05-30ActionInterim Dividend - Rs 3 Per ShareDividend
- 2024-09-23ActionDividend - Rs 2.50 Per ShareDividend
- 2024-09-23ActionAnnual General MeetingMeeting
- 2024-08-26BulkBUY Β· βΉ75.3 CrGRAVITON RESEARCH CAPITAL LLP
- 2024-08-26BulkSELL Β· βΉ75.4 CrGRAVITON RESEARCH CAPITAL LLP
- 2024-08-26NetDay net ββΉ0.1 Cr
- 2024-08-19BulkSELL Β· βΉ78.4 CrGRAVITON RESEARCH CAPITAL LLP
- 2024-08-19BulkBUY Β· βΉ78.3 CrGRAVITON RESEARCH CAPITAL LLP
- 2024-08-19NetDay net ββΉ0.1 Cr
Merged from deals, filings, corporate actions and news β newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF β
4 deals Β· 2024-08-19 β 2024-08-26
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2024-08-26 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | BUY | βΉ75.3 Cr |
| 2024-08-26 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | SELL | βΉ75.4 Cr |
| 2024-08-19 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | SELL | βΉ78.4 Cr |
| 2024-08-19 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | BUY | βΉ78.3 Cr |
4 deals in the selected window β corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on CAPLIPOINT
RSS News
0No recent news.
Google News RSS β links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.